Smartwatches could revolutionize monitoring of rare nerve disease

NCT ID NCT07273903

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether smartwatches can help monitor chronic inflammatory demyelinating polyneuropathy (CIDP), a rare nerve disease that causes weakness and numbness. 35 adults with CIDP who use subcutaneous immunoglobulin therapy at home will wear a smartwatch for 12 months. Researchers will compare step counts and activity levels with standard clinical tests to see if the watch can detect changes in disease severity or treatment response.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

subcutaneous immunoglobulin (fSCIG)

What this could lead to

If successful, this could show that smartwatches help doctors monitor CIDP more closely and adjust treatment earlier, leading to better long-term care.

What could go wrong

This is a small, early observational study (35 people) that does not test a new treatment. The smartwatch data may not reliably reflect disease changes, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic inflammatory demyelinating polyradiculoneuropathy polyneuropathy, inflammatory demyelinating, chronic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital Düsseldorf

    RECRUITING

    Düsseldorf, North Rhine-Westphalia, 40225, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Münster

    RECRUITING

    Münster, North Rhine-Westphalia, 48149, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••